DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
DRUG fundamentals
Bright Minds (DRUG) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2918 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2918
--
Report date
Aug 11, 2025
EPS
Actual | -1.5185 | -0.8541 | -0.1256 | 0.0069 | -0.2918 | |||||||
Forecast | -0.4434 | -0.0156 | -0.3013 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +71.67% | +144.23% | +3.15% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Bright Minds's latest dividend and current dividend yield?What guidance did Bright Minds's management provide for the next earnings period?What is the market's earnings forecast for Bright Minds next quarter?Did Bright Minds beat or miss consensus estimates last quarter?What does Bright Minds do and what are its main business segments?What were the key takeaways from Bright Minds's earnings call?What is Bright Minds's gross profit margin?What is the revenue and EPS growth rate for Bright Minds year over year?
